Cargando...
BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
Choice of the optimal therapy for BCLC-B hepatocellular carcinoma (HCC) is a significant clinical problem. Transarterial chemoembolisation (TACE) is considered to be the method of choice as this approach is reported to produce a direct effect and to have a significant survival rate. However, TACE is...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
Remedium Group LLC
2018-07-01
|
| Colección: | Медицинский совет |
| Materias: | |
| Acceso en línea: | https://www.med-sovet.pro/jour/article/view/2529 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|